CORRECTION: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease
dc.contributor.author | Ray, Balmiki | |
dc.contributor.author | Maloney, Bryan | |
dc.contributor.author | Sambamurti, Kumar | |
dc.contributor.author | Karnati, Hanuma K. | |
dc.contributor.author | Nelson, Peter T. | |
dc.contributor.author | Greig, Nigel H. | |
dc.contributor.author | Lahiri, Debomoy K. | |
dc.contributor.department | Psychiatry, School of Medicine | en_US |
dc.date.accessioned | 2023-04-18T10:03:45Z | |
dc.date.available | 2023-04-18T10:03:45Z | |
dc.date.issued | 2020-03-02 | |
dc.description.abstract | Correction to: Translational Psychiatry 10.1038/s41398-020-0709-x published online 03 February 2020 The original article contained few errors: Hanuma K. Karnati’s name was misstated in the author list, references 2 and 55 referred to the wrong sources, and the authors wanted to expand on their discussion of ChEIs on page 13. These errors have all been updated in the XML, PDF, and HTML versions of this article. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Ray B, Maloney B, Sambamurti K, et al. Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease. Transl Psychiatry. 2020;10(1):81. Published 2020 Mar 2. doi:10.1038/s41398-020-0757-2 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/32460 | |
dc.language.iso | en_US | en_US |
dc.publisher | Springer Nature | en_US |
dc.relation.isversionof | 10.1038/s41398-020-0757-2 | en_US |
dc.relation.journal | Translational Psychiatry | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | * |
dc.source | PMC | en_US |
dc.subject | Corrections | en_US |
dc.subject | Erratum | en_US |
dc.subject | Amendments | en_US |
dc.title | CORRECTION: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease | en_US |
dc.type | Article | en_US |